Ramsay Health Care Lifts CEO Maximum LTI Opportunity

MT Newswires Live

Sep 24

Ramsay Health Care (ASX:RHC) has raised Group Chief Executive Natalie Davis' maximum long-term incentive (LTI) opportunity to 170% of fixed annual remuneration (FAR) from 150%, effective fiscal 2027, following a periodic review, according to a Thursday Australian bourse filing.

The FAR remains unchanged at AU$1.8 million, while the short-term incentive remains unchanged at 100% of FAR at target and 150% at maximum, per the filing.

The LTI will continue to be provided through performance rights, subject to vesting conditions and shareholder approval, while the existing 12-month restraint provision remains unchanged, the filing added.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/2669043280"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2669043280\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2669043280?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-24 07:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2669043280","market":"nz","top_or_hot":-1,"title":"Ramsay Health Care Lifts CEO Maximum LTI Opportunity","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/RMSYF\">Ramsay Health Care</a> (ASX:RHC) has raised Group Chief Executive Natalie Davis' maximum long-term incentive (LTI) opportunity to 170% of fixed annual remuneration (FAR) from 150%, effective fiscal 2027, following a periodic review, according to a Thursday Australian bourse filing.</p><p>The FAR remains unchanged at AU$1.8 million, while the short-term incentive remains unchanged at 100% of FAR at target and 150% at maximum, per the filing.</p><p>The LTI will continue to be provided through performance rights, subject to vesting conditions and shareholder approval, while the existing 12-month restraint provision remains unchanged, the filing added.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ramsay Health Care Lifts CEO Maximum LTI Opportunity</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRamsay Health Care Lifts CEO Maximum LTI Opportunity\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-09-24 07:51</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/RMSYF\">Ramsay Health Care</a> (ASX:RHC) has raised Group Chief Executive Natalie Davis' maximum long-term incentive (LTI) opportunity to 170% of fixed annual remuneration (FAR) from 150%, effective fiscal 2027, following a periodic review, according to a Thursday Australian bourse filing.</p><p>The FAR remains unchanged at AU$1.8 million, while the short-term incentive remains unchanged at 100% of FAR at target and 150% at maximum, per the filing.</p><p>The LTI will continue to be provided through performance rights, subject to vesting conditions and shareholder approval, while the existing 12-month restraint provision remains unchanged, the filing added.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"FAR.AU","symbol_name":"FAR LTD","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2669043280","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2669043280","pubTimestamp":1790207462,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Ramsay Health Care  has raised Group Chief Executive Natalie Davis' maximum long-term incentive  opportunity to 170% of fixed annual remuneration  from 150%, effective fiscal 2027, following a periodic review, according to a Thursday Australian bourse filing.The FAR remains unchanged at AU$1.8 million, while the short-term incentive remains unchanged at 100% of FAR at target and 150% at maximum, per the filing.The LTI will continue to be provided through performance rights, subject to vesting conditions and shareholder approval, while the existing 12-month restraint provision remains unchanged, the filing added.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"FAR.AU":"FAR LTD","BK4581":"高盛持仓","XLV":"健康照护类股ETF-SPDR","RHC.AU":"RAMSAY HEALTH CARE LTD","BK7142":"石油与天然气的勘探与生产","LABU":"三倍做多标普生物-Direxion","BK4585":"ETF&股票定投概念","XBI":"SPDR S&P Biotech ETF","BK4588":"碎股","BK7113":"保健护理机构"},"translate_title":"Ramsay Health Care 为首席执行官提供最大 LTI 机会","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LABU":0.6,"RHC.AU":1.5,"XLV":1.5,"FAR.AU":1,"XBI":0.6},"content_text":"Ramsay Health Care (ASX:RHC) has raised Group Chief Executive Natalie Davis' maximum long-term incentive (LTI) opportunity to 170% of fixed annual remuneration (FAR) from 150%, effective fiscal 2027, following a periodic review, according to a Thursday Australian bourse filing.The FAR remains unchanged at AU$1.8 million, while the short-term incentive remains unchanged at 100% of FAR at target and 150% at maximum, per the filing.The LTI will continue to be provided through performance rights, subject to vesting conditions and shareholder approval, while the existing 12-month restraint provision remains unchanged, the filing added.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"executive","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}